In the present study, using ovarian cancer cellular and tumor model systems, we sought to investigate whether, similar to DR5, Fas exploits the negative regulatory PPCR motif for its optimal receptor clustering, signaling, and death activation by agonist antibodies and bystander CAR-T function. This evidence concerns the gene FAS and ovarian carcinoma.